University of California San Francisco
Give to UCSF
Special Notice Concerning COVID-19
Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
Displaying 1 - 30 of 515
-
-
Treating Anal Cancer Precursor Lesions Reduces Cancer Risk for People With HIV
A groundbreaking national study led by UCSF finds that treating anal cancer precursor lesions reduces cancer risk for people with HIV.
-
Flu Shots and COVID: Do You Need to Worry About Vaccine Timing? What About a ‘Twindemic’?
-
How ‘fits and starts’ of booster science, rollout may affect U.S. vaccination goals
-
Community-Based Strategy Succeeds in Vaccinating Latinx San Franciscans
A community-based effort to overcome vaccine hesitancy designed by UCSF scientists working together with San Francisco’s Latino Task Force is succeeding in the Mission District of San Francisco.
-
Evaluating the New Mu Variant in California
-
Arthur Ammann, UCSF Doctor Who Discovered AIDS Virus in Infants, Dies at 85
-
Severe Infections During Pregnancy Associated With Complications Around Childbirth
Individuals who are hospitalized during pregnancy due to sepsis have higher odds of complications surrounding childbirth, according to a study led by researchers at UCSF. The study found that pregnancies complicated by sepsis were associated with an increased risk of cesarean delivery, postpartum hemorrhage and preterm delivery, highlighting the risk of any severe infection during pregnancy.
-
Data-Driven Drug Dosing Speeds Tuberculosis Treatment to 4 Months
A clinical trial of new treatment regimens, led in part by researchers at UCSF, recently demonstrated that a more potent combination of antibiotics could shorten the duration of treatment for TB.
-
COVID-19 Vaccines Produce Immune Responses in Patients With Chronic Inflammatory Diseases
Most patients on immunosuppressive drugs for chronic inflammatory conditions, like rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease, can still produce antibodies after receiving the mRNA COVID-19 vaccines, researchers at UCSF and Washington University have concluded.
-
COVID-19 During Pregnancy Associated with Preterm Birth
Individuals who contract COVID-19 while pregnant face a higher risk of having a very preterm birth, as well as any preterm birth.
-
Should the Delta Variant Change Your Decisions About Covid-19? Here’s What Doctors Are Doing
-
How Dangerous Is the Delta Variant? Here’s What the Science Says
We spoke to UCSF virologist Nadia Roan, PhD, about the latest developments in our knowledge of the Delta variant, including how the new variant spreads so efficiently, whether it causes more serious illness, and why she thinks vaccines will hold the line.
-
UCSF Responds to Surge in COVID-19 Cases Among Employees, Learners
UCSF is responding to an increase in the number of community-acquired COVID-19 cases among its employees and learners.
-
UCSF to House COVID Tracking Project, a National Database Donated by The Atlantic
UCSF and The Atlantic have announced that the crowdsourced digital archive documenting the face of the pandemic in the United States will become part of the University’s permanent library collection and is accessible to researchers and the public.
-
UCSF Co-led Study Demonstrates Safety and Efficacy of 4-Month Tuberculosis Treatment Regimen
UCSF researchers in collaboration with the Centers for Disease Control’s Tuberculosis Trials Consortium and the AIDS Clinical Trials Group published a landmark study that demonstrated a new four-month treatment regimen for tuberculosis was safe and as efficacious as the standard six-month therapy.
-
Faster Test Results Mean Better Outcomes For HIV Patients
Scientists at UCSF and Makerere University in Kampala, Uganda have developed an intervention that makes use of a portable laboratory testing technology to help HIV providers order, process, and receive HIV viral load results quickly, and shorten the time it takes for patients to get their results.
-
No Sign of COVID-19 Vaccine in Breast Milk
Messenger RNA vaccines against COVID-19 were not detected in human milk, according to a small study by UCSF, providing early evidence that the vaccine mRNA is not transferred to the infant.
-
Common COVID-19 Antibiotic No More Effective Than Placebo
A UCSF study has found that the antibiotic azithromycin was no more effective than a placebo in preventing symptoms of COVID-19 among non-hospitalized patients, and may increase their chance of hospitalization, despite widespread prescription of the antibiotic for the disease.
-
The Reassuring Data on the Delta Variant
-
Vaccine Hesitancy in Young Adults May Hamper Herd Immunity
A study by UCSF researchers found that about one in four unvaccinated people aged 18 to 25 said that they “probably will not” or “definitely will not” get the COVID-19 vaccination.
-
Doctors Investigate Rare COVID Breakthrough Cases Infecting Vaccinated Californians
-
Yes, the Delta Variant Is Taking Over. But the Vaccines Still Work.
-
COVID-19 Vaccines Don’t Infiltrate Breast Milk, Study Shows
-
7 Questions About COVID-19 Booster Shots, Answered
-
Mutation in Highly Infectious Alpha Variant May Help Coronavirus Evade Immune System
The B.1.1.7 coronavirus variant—also known as Alpha—may be more infectious because it contains mutations that make it better adapted to foil the innate immune system, at least for long enough to allow the virus to replicate and potentially find new hosts, according to a new study.
-
Is It Over? How California Will Know When the Pandemic Ends
-
Coronavirus Delta Variant ‘May Hit Us Pretty Hard’ This Fall. Here’s What You Need to Know
-
How Can We Thwart the Next Pandemic?
Leading scientists share some of the tools and strategies that could help us better confront and contain future outbreaks.
-
Your Immune System Could Turn COVID-19 Deadly
Hidden autoimmunity may explain how the coronavirus wreaks such widespread and unpredictable harm.
